Carter T. Fields

2.3k citations
11 papers · 2k · 1 hit paper · h-index 10

Impact in

  • Oncology top 5%
    • HER2/EGFR in Cancer Research
    • Cancer Cells and Metastasis
  • Genetics top 5%
    • Inflammatory Bowel Disease

Papers in

    • HER2/EGFR in Cancer Research 5
    • Cancer Cells and Metastasis 1
    • Microtubule and mitosis dynamics 2

Carter T. Fields

11 papers receiving 1.9k citations

Carter T. Fields's Hit Papers

Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941 2009 · 718 citations
7180+5+11Years since publication200400600

Peers

Carter T. Fields
Comparison fields: 5 of 70
  • Oncology 836
  • Genetics 431
  • Radiology, Nuclear Medicine and Imaging 269
  • Cancer Research 97
  • Cell Biology 59
Replace Neil Johnson with:
Neil Johnson United States
Stefanie Avril United States
Ronald N. Buick Canada
Joshua D. Parsels United States
Janneke E. Jaspers Netherlands
Robert M. Hudziak United States
Urszula M. Polanska United Kingdom
Louise J. Barber United Kingdom
Jean‐Gabriel Judde France
Brian Belmontes United States
Carter T. Fields relative to Neil Johnson United States Neil Johnson's profile →
Citations per field
00.5×1.5×2.1×
Neil Johnson · 1×
Citations per year

Countries citing papers authored by Carter T. Fields

Since Specialization
Citations

This map shows the geographic impact of Carter T. Fields's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carter T. Fields with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carter T. Fields more than expected).

Fields of papers citing papers by Carter T. Fields

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carter T. Fields. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carter T. Fields. The network helps show where Carter T. Fields may publish in the future.

Co-authors

The 25 scholars most cited alongside Carter T. Fields, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carter T. Fields Line = papers co-authored together Carter T. Fields links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1
Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941
Hit paper breakdown →
2009718
2 1998338
3 2011287
4 2013168
5 2015156
6 1998129
7 200972
8 200850
9 202442
10 201117
11 19983

About Carter T. Fields

Carter T. Fields is a scholar working on Oncology, Cell Biology, Genetics, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 11 papers that have together received 2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), Inflammatory Bowel Disease (3 papers), Microtubule and mitosis dynamics (2 papers) and Cancer Cells and Metastasis (1 paper). The work is most often cited by research in Oncology (836 citations), Genetics (431 citations), Radiology, Nuclear Medicine and Imaging (269 citations), Cancer Research (97 citations) and Cell Biology (59 citations). Carter T. Fields has collaborated with scholars based in United States and France. Frequent co-authors include Gail D. Lewis Phillips, Mark X. Sliwkowski, Teemu T. Junttila, Robert W. Akita, Deepak Sampath, Lori S. Friedman, Kathryn L. Parsons, Ethylin Wang Jabs, Jasdeep Mann and Judy H. Cho. Their work appears in journals such as Cancer Cell, Gastroenterology, Journal of Medicinal Chemistry, Clinical Cancer Research and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact